Function-modulating human monoclonal antibodies against platelet-membrane receptors isolated from a phage-display library

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 8, 2003, Pages 1829-1836

  Hagay, Y ^a   Lahav, J ^b   Levanon, A ^a   Panet, A ^c  

^a Bio Technology General Inc   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

GPIB; Phage display antibodies library; Platelet; Receptor

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; GLYCOCALICIN; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; BINDING SITE; CELL MEMBRANE; CHEMISTRY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; SEQUENCE HOMOLOGY; THROMBOCYTE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING SITES; BINDING, COMPETITIVE; BLOOD PLATELETS; BLOTTING, WESTERN; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYTIC AGENTS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; VON WILLEBRAND FACTOR;

EID: 2142660654     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00386.x     Document Type: Article

References (41)

1. Sakariassen KS, Fressinaud E, Girma JP, Meyer D, Baumgartner HR. Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen. Ann NYAcad Sci 1987; 516: 52-65.
2. Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992; 13: 100-5.
3. Kroll MH, Heliums JD, Mclntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
4. Hawiger J. Platelets: receptors, adhesion, secretion. Methods Enzymol 1992; 169: 131-6.
5. De Marco L, Girolami A, Russell S, Ruggeri ZM. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 1985; 75: 1198-203.
6. Ruggeri ZM, Ware J. Von Willebrand factor. FASEB J 1993; 7: 308-16.
7. Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 1997; 100: S57-60.
8. Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76: 101-8.
9. Tcheng JE, Ellis SG, George BS, Kereiakes DJ, Kleiman NS, Talley JD, Wang AL, Weisman HF, Califf RM, Topol EJ. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 1994; 90: 1757-64.
10. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making anti-bodiesbyphagedisplaytechnology.Annu Rev Immunol 1994; 12:433-55.
11. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-4.
12. Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J 1994; 13: 692-8.
13. Carter P, Bedouelle H, Winter G. Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucl Acids Res 1985; 13: 4431-43.
14. Harrison JL, Williams SC, Winter G, Nissim A. Phage display libraries. Methods Enzymol 1996; 267: 83-109.
15. Hoogenboom HR, Winter G. By-passing immunisation. Human anti bodies from synthetic repertoires of germline VH gene segments rear ranged in vitro. J Mol Biol 1992; 227: 381-8.
16. de Kruif J, van der Vuurst de Vries AR, Cilenti L, Boel E, van Ewijk W, Logtenberg T. New perspectives on recombinant human antibodies. Immunol Today 1996; 17: 453-5.
17. Vitaliti A, Wittmer M, Steiner R, Wyder L, Neri D, Klemenz R. Inhibition of tumor angiogenesis by a single-chain antibody directed against vas cular endothelial growth factor. Cancer Res 2000; 60: 4311-4.
18. Parsons HL, Earnshaw JC, Wilton J, Johnson KS, Schueler PA, Ma-honey W, McCafferty J. Directing phage selections towards specific epitopes. Protein Eng 1996; 9: 1043-9.
19. Van Ewijk W, de Kruif J, Germeraad WT, Berendes P, Ropke C, Platenburg PP, Logtenberg T. Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc Natl Acad Sci USA 1997; 94: 3903-8.
20. Cai X, Garen A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci USA 1995; 92: 6537-41.
21. Pereira S, Van Belle P, Elder D, Maruyama H, Jacob L, Sivanandham M, Wallack M, Siegel D, Herlyn D. Combinatorial antibodies against human malignant melanoma. Hybridoma 1997; 16: 11-6.
22. Noronha EJ, Wang X, Desai SA, Kageshita T, Ferrone S. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells. J Immunol 1998; 161: 2968-76.
23. de Kruif J, Terstappen L, Boel E, Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci USA 1995; 92: 3938-42.
24. Edwards BM, Main SH, Cantone KL, Smith SD, Warford A, Vaughan TJ. Isolation and tissue profiles of a large panel of phage antibodies binding to the human adipocyte cell surface. J Immunol Methods 2000; 245: 67-78
25. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994; 13: 3245-60.
26. Gralnick HR, Williams S, McKeown L, Kramer W, Krutzsch H, Gorecki M, Panet A, Garfinkel LI. A monomeric von Willebrand factor frag ment, Leu-504-Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX. Proc Natl Acad Sci USA 1992; 89: 7880-4.
27. Gralnick HR, Williams SB, McKeown LP, Magruder L, Hansmann K, Vail M, Parker RI. Platelet von Willebrand factor. Mayo Clin Proc 1991; 66: 634-40.
28. Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC. Purifica tion of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochem istry 1989; 28: 8317-26.
29. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis (sulfosuccinimidyl) suberate. Biochemistry 1989; 28: 8326-36.
30. Li M. Applications of display technology in protein analysis. Nature Biotechnol 2000; 18: 1251-6.
31. Kjaer S, Wind T, Ravn P, Ostergaard M, Clark BF, Nissim A. Generation and epitope mapping of high-affinity scFv to eukaryotic elongation factor 1A by dual application of phage display. Eur J Biochem 2001; 268: 3407-15.
32. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994; 5: 97-119.
33. Lopez JA, Dong JF. Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 1997; 4: 323-9.
34. Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycopro tein Ib. Proc Natl Acad Sci USA 1987; 84: 5610-4.
35. McGhie Al, McNatt J, Ezov N, Cui K, Mower LK, Hagay Y, Buja LM, Garfinkel LI, Gorecki M, Willerson JT. Abolition of cyclic flow varia tions in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation 1994; 90: 2976-81.
36. Yao SK, Ober JC, Garfinkel LI, Hagay Y, Ezov N, Ferguson JJ, Anderson HV, Panet A, Gorecki M, Buja LM et al. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogen-esis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation 1994; 89: 2822-8.
37. Bennett JS. Novel platelet inhibitors. Annu Rev Med 2001; 52: 161-84.
38. Gurevitz O, Goldfarb A, Hod H, Feldman M, Shenkman B, Varon D, Eldar M, Inbal A. Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis model. Arterioscler Thromb Vase Biol 1998; 18: 200-7.
39. Cauwenberghs N, Meiring M, Vauterin S, van Wyk V, Lamprecht S, Roodt JP, Novak L, Harsfalvi J, Deckmyn H, Kotze HE Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Arterioscler Thromb Vase Biol 2000; 20: 1347-53.
40. Yeh CH, Chang MC, Peng HC, Huang TF. Pharmacological character ization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. Br J Pharmacol 2001; 132: 843-50.
41. Hoogenboom HR. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol 1997; 15: 62-70.